403651-41-2

Upstream product

• 403651-36-5 (-)-2,4,5,6-tetra-O-benzyl-1-O-(p-methoxybenzyl)-3-deoxy-3-methylene-myo-inositol 
• 403651-35-4 (-)-2,4,5,6-tetra-O-benzyl-1-O-(p-methoxybenzyl)-3-deoxy-3-oxo-myo-inositol 
• 141040-56-4 (+)-2,4,5,6-tetra-O-benzyl-1-O-(p-methoxybenzyl)-myo-inositol 
• 403651-37-6 (-)-2,4,5,6-tetra-O-benzyl-1-O-(p-methoxybenzyl)-3-deoxy-3-hydroxymethyl-myo-inositol 

Downstream Products

• 403651-49-0 (-)-2,4,5,6-tetra-O-benzyl-3-deoxy-3-iodomethyl-myo-inositol 

Relevant academic research and scientific papers

Synthesis and biological evaluation of L-α-Phosphatidyl-D-3-deoxy-3-heteromethyl-myo-inositols as phosphoinositide 3-kinase inhibitors

We have synthesized a series of 3-deoxy-3-heteromethyl derivatives of L-α-phosphatidyl-D-myo-inositol as part of our effort to develop specific, reversible inhibitors of phosphoinositide (PI) 3-kinase. Among various derivatives examined, phosphatidyl-D-3-